1 Department of General Surgery, Yiling Hospital of Yichang City, Yichang, Hubei, China 2 College of Basic Medical Sciences, China Three Gorges University, Yichang, Hubei, China Objectives: As obesity ...
Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to ...
HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...
HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies.
US FDA grants orphan drug designation to HanchorBio’s HCB101 to treat gastric cancer: Taipei, Shanghai Monday, February 16, 2026, 17:00 Hrs [IST] HanchorBio, Inc., a global clin ...
Gastroenterologist Dr Wendi LeBrett warned that acid reflux, an ailment which most people consider to be minor, can lead to something more sinister.
The US regulator granted special designation to the biotech company's HCB101 candidate, providing development incentives for the rare disease treatment.
The U.S. FDA has granted orphan drug designation to HCB101, an investigational immunotherapy, for the treatment of gastric cancer.
(TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results